National Account Director, Managed Markets

The National Account Director will report to the Sr. Director, Managed Markets and will lead/manage National/Regional Payer and PBM customer relationships and deliver profitable access, reimbursement, and appropriate policy for Corcept brands. The person will work collaboratively with the broader Corcept Commercial organization including Sales, Marketing, Medical, Commercial Operations, etc. The NAD will be responsible for helping create key communication strategies for approved therapies and assist with preapproval information exchange for products with NDA filings. The goal of this position is to minimize Korlym access barriers and develop strategies for long-term access solutions for our pipeline.Responsibilities:In coordination with Market Access Leadership, develops a market access strategy aligned with Corcept’s commercial goals and ensures a comprehensive tactical plan is deployed to achieve commercial strategic objectives.Establish strong relationships with Pharmacy Directors, Medical Directors, and other strategic personnel within key assigned accounts.Deliver value proposition and Health Economic Information (HEI) to educate payers, formulary committees, and similar entities, on product(s) and economic benefit.Create, implement, and maintain detailed account plans for targeted accounts, including pre-launch, launch, and post-launch activities to maximize access and reimbursement.Ensure rapid and optimal access for all Corcept products.Provide appropriate insights and inputs into the development of payer PAs and/or Medical Policies.Assess sales implications of short- and long-term actions with each payer customer and take action to move payer decisions in a direction that continues to open patient access to care with Corcept products.Negotiate and measure contract performance (if applicable) with target accounts based on approved strategies.Collaborate with field teams (Sales, Medical, Patient Advocates, etc.) to identify any access barriers and partner with colleagues to mitigate.Work collaboratively with Specialty Pharmacy partners to ensure reimbursement confidence and unimpeded access in alignment with product FDA label.Provide periodic market updates to Commercial Leadership that link important provider, payer, and health care reform trends and issues as well as document initiatives and their outcomes.Ensures all activities are consistent with all US Healthcare regulations, laws, and company compliance policies.Preferred Skills, Qualifications and Technical Proficiencies:Deep insight into customer, policy, benefit, clinical evaluation, and legislation impact on the customer and the market.Demonstrated ability to navigate deep into the payer/PBM, manage executive engagements, foster customer touch points within Pharmacy, Medical, policy, and reimbursement.Strategic problem-solver; analytical and decisive.Moves beyond the traditional ways of doing things; pushes the status quo. Continually assesses the market potential of innovative ideas and solutions and builds strong business cases for the customer and Corcept to support the initiative.Preferred Education and Experience:Bachelor’s degree, MBA preferred.Candidate should have 10+ years of proven success in biotech/pharmaceutical industry (large account management experience is preferred) that includes:Minimum of 5 years experience executing market access strategies for National PBM and Payer accounts, and exposure to contract development and negotiations.Endocrinology and Oncology experience preferred.Proven credibility in gaining accelerated access to key decision-makers and influencers with time efficiency.Strong understanding of the US healthcare landscape, policy, and reimbursement.Success in building relationships with key contacts in highly matrixed organizations.Success in implementing system-wide initiatives, including formulary process.Experience negotiating and implementing pharmacy and medical policy for portfolio.Experience delivering value propositions and using health economic models.Ability to travel up to 50% of the time for customer engagements, and internal meetings.

#J-18808-Ljbffr